Beiträge

  • Prof. Dr. med. Dr. phil. Torsten Haferlach
    from 30.09.2020
    BELUGA - A Prospective, Registered Study on the Use of Artificial Intelligence (AI) in Hematology

    Even before the start of the COVID-19 pandemic, we saw how strongly digitalization is shaping our private and professional lives and will continue to do so in the future. This also applies to innovations for daily work in the paperless Munich Leukemia Laboratory (MLL), such as the complete digitalization of all medical findings in a constantly improving digital infrastructure. However, AI will mark a new era for medical diagnostic services as well. 

    Post review
    Read article
  • Dr. rer. nat. Ines Schmidts
    from 18.02.2020
    The Use of Artificial Intelligence at MLL Munich Leukemia Laboratory

    Whether a search engine or digital assistant is involved, artificial intelligence (AI) has long been a part of our day-to-day work. There are success stories in imaging-based diagnostics thanks to AI as well. Preliminary studies, for example, indicate that the classification of medical findings using AI is equivalent to traditional methods.

    Post review
    Read article
  • Niroshan Nadarajah
    from 18.11.2019
    MLLi:ir - A diagnostic interpretation report for NGS data

    Making a patient disease diagnosis on the basis of Next-Generation Sequencing (NGS) data is a complex endeavor. To be able to make an exact diagnosis, medical professionals must be able to access all the available information pertaining to the specific genetic variants detected.

    Post review
    Read article